Trial
NCT00257192
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Schizophrenia
Intervention
placebo
Why stopped
Please see Detailed Description for termination reason.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-25